ShopSpell

Myeloid Leukemia Methods and Protocols [Hardcover]

$91.99     $109.99    16% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  1588294854
  • ISBN-10:  1588294854
  • ISBN-13:  9781588294852
  • ISBN-13:  9781588294852
  • Publisher:  Humana
  • Publisher:  Humana
  • Pages:  320
  • Pages:  320
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-Mar-2005
  • Pub Date:  01-Mar-2005
  • SKU:  1588294854-11-SPRI
  • SKU:  1588294854-11-SPRI
  • Item ID: 100839136
  • List Price: $109.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Jul 05 to Jul 07
  • Notes: Brand New Book. Order Now.
A panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered.A panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered.Isolation of RNA and DNA From Leukocytes and cDNA SynthesisJoop H. Jansen and Bert A. van der ReijdenCytogenetic and FISH Techniques in Myeloid MalignanciesLynda J. CampbellOverview of Real-Time RT-PCR Strategies for Quantification of Gene Rearrangements in the Myeloid MalignanciesChristophe Picard, Monique Silvy, and Jean GabertDiagnosis and Monitoring of Chronic Myeloid Leukemia by Qualitative and Quantitative RT-PCRlC™
Add Review